Investor Relations

IR Home

Conformis Profile Image
Corporate Profile
Founded in 2004, Conformis is a medical technology company focused on advancing orthopedic patient care and creating a world without joint pain. Its product portfolio is designed to maximize surgeon and patient choice by offering fully personalized solutions through its Image-to-Implant® Platinum Services℠ Program as well as data-informed, standardized solutions that combine many benefits of personalization with the convenience and flexibility of an off-the-shelf system... more >

Stock Quote

Stock Quote
(Common Stock)
Change :  
Volume :
Data as of  

IR Home

more >
Recent News
11/30/22
Conformis, Inc. Regains Compliance with Nasdaq’s Minimum Bid Price Rule
BILLERICA, Mass. , Nov. 30, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that it received a letter from the Listing Qualifications Department of The NASDAQ Stock Market (“NASDAQ”) on November 25, 2022 notifying Conformis that, based on the closing bid price of Conformis’
11/29/22
Conformis Announces First Procedure Performed Using New Actera™ Hip System
First Actera™ procedure underscores company’s ongoing commitment to advancing joint replacement technology by leveraging its data-driven approach and surgical planning expertise BILLERICA, Mass. , Nov. 29, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a leading medical device company that
more >
Upcoming Events
More events are coming soon.
IR Contact  
Investor Relations
Phone: (781) 374-5598
E-mail: ir@conformis.com
Featured Reports

Data Provided by Refinitiv. Minimum 15 minutes delayed.